Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1277
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06283251 | PediRISE Feasibility | ||
| NCT02880319 | Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone | ||
| NCT04043845 | ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies | ||
| NCT06795139 | Pilot of a Trial Enrollment Diversity Dashboard | ||
| NCT05403801 | STAMP+CBT mHealth for Cancer Pain | ||
| NCT00137826 | Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma | ||
| NCT06317220 | Vedolizumab for the Treatment of Collagenous Gastritis | ||
| NCT00137839 | Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung | ||
| NCT05587439 | Investigating Hereditary Risk In Thoracic Cancers (INHERIT) | ||
| NCT07052695 | Mosunetuzumab for CLL MRD Clearance | ||
| NCT06964009 | DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer | ||
| NCT04724018 | Sacituzumab Govitecan Plus EV in Metastatic UC | ||
| NCT00307723 | Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer | ||
| NCT02999477 | A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer | ||
| NCT00003200 | Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck | ||
| NCT00148707 | Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer | ||
| NCT06335745 | PediCARE Health Equity Intervention in High-Risk Neuroblastoma | ||
| NCT01912963 | Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast Cancer | ||
| NCT03436654 | Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma | ||
| NCT00361231 | Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer | ||
| NCT03576872 | The GI Binder: A Psychoeducational Intervention for Gastrointestinal Cancer Patients | ||
| NCT05011279 | Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives) | ||
| NCT06709495 | Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas | ||
| NCT02873962 | A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib | ||
| NCT02244463 | A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer | ||
| NCT05783609 | Epcoritamab and Rituximab for First-line Follicular Lymphoma | ||
| NCT03929029 | Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma | ||
| NCT02770014 | Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer | ||
| NCT01783587 | Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer | ||
| NCT03660228 | Peri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDS | ||
| NCT03093428 | Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC | ||
| NCT01753089 | Dendritic Cell Activating Scaffold in Melanoma | ||
| NCT00003761 | Vaccine Therapy in Treating Patients With Metastatic Breast Cancer | ||
| NCT03051672 | Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC | ||
| NCT00543114 | Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL | ||
| NCT02925533 | Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial Tract | ||
| NCT00813293 | Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer | ||
| NCT00804336 | Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors | ||
| NCT06803875 | Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma | ||
| NCT00258687 | Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma | ||
| NCT06458049 | Sexual Health and Rehabilitation Online (SHAREonline) | ||
| NCT00874562 | Rapamycin in Relapsed Acute Lymphoblastic Leukemia | ||
| NCT03057145 | Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors | ||
| NCT01741753 | BKM120+Abiraterone Acetate for Metastatic CRPC | ||
| NCT03765983 | GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases | ||
| NCT00153894 | Effects of Exercise Intervention on Insulin Levels in Breast Cancer Survivors | ||
| NCT00436072 | ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer | ||
| NCT01959542 | Early Changes In Multiparametric MRI In Prostate Cancer | ||
| NCT02756390 | CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors | ||
| NCT00142168 | CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia |
